LETTERS TO THE EDITOR on the gestational outcome, and we agree with Prof. Dr Kotaska that continued research with these microorganisms is needed. In addition, we also recognise that a randomised trial of treatment or placebo in infected women is the best study design to verify the risk of genital mycoplasma infection in preterm birth and the influence of treatment in this outcome.